Chemotherapy-induced peripheral neurotoxicity in cancer survivors: an underdiagnosed clinical entity?
- PMID: 25993222
- DOI: 10.14694/EdBook_AM.2015.35.e553
Chemotherapy-induced peripheral neurotoxicity in cancer survivors: an underdiagnosed clinical entity?
Abstract
Systemic chemotherapy is a cornerstone of the modern medical management of cancer, although its use is limited by toxicity on normal tissues and organs, including the nervous system. Long-surviving or cured people strongly require a high level of wellness in addition to prolongation of life (the concept of the quality of survival), but neurologic dysfunction can severely affect daily life activities. Chemotherapy-related peripheral neurotoxicity is becoming one of the most worrisome long-term side effects in patients affected by a neoplasm. The central nervous system has a limited capacity to recover from injuries, and it is not surprising that severe damage can determine long-term or permanent neurologic dysfunction. However, the peripheral nervous system also can be permanently damaged by anticancer treatments despite its better regeneration capacities, and the effect on patients' daily life activities might be extremely severe. However, only recently, the paradigms of peripheral neurotoxicity reversibility have been scientifically challenged, and studies have been performed to capture the patients' perspectives on this issue and to measure the effect of peripheral neurotoxicity on their daily life activities. Despite these efforts, knowledge about this problem is still largely incomplete, and further studies are necessary to clarify the several still-unsettled aspects of long-term peripheral neurotoxicity of conventional and targeted anticancer chemotherapy.
Similar articles
-
Challenges Evaluating Chemotherapy-Induced Peripheral Neuropathy in Childhood Cancer Survivors.J Pediatr Oncol Nurs. 2017 Mar/Apr;34(2):106-114. doi: 10.1177/1043454216651016. Epub 2016 Jul 7. J Pediatr Oncol Nurs. 2017. PMID: 27251891 Review.
-
Approaches to measure paediatric chemotherapy-induced peripheral neurotoxicity: a systematic review.Lancet Haematol. 2020 May;7(5):e408-e417. doi: 10.1016/S2352-3026(20)30064-8. Lancet Haematol. 2020. PMID: 32359452 Free PMC article.
-
In vitro neurotoxicity testing: lessons from chemotherapy-induced peripheral neurotoxicity.Expert Opin Drug Metab Toxicol. 2024 Nov-Dec;20(11-12):1037-1052. doi: 10.1080/17425255.2024.2401584. Epub 2024 Sep 10. Expert Opin Drug Metab Toxicol. 2024. PMID: 39246127 Review.
-
Neurologic Complications of Systemic Anticancer Therapy.Neurol Clin. 2018 Aug;36(3):627-651. doi: 10.1016/j.ncl.2018.04.013. Neurol Clin. 2018. PMID: 30072074 Review.
-
Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools.Eur J Cancer. 2010 Feb;46(3):479-94. doi: 10.1016/j.ejca.2009.12.008. Epub 2010 Jan 4. Eur J Cancer. 2010. PMID: 20045310 Review.
Cited by
-
Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy-Induced Peripheral Neurotoxicity.Neurology. 2021 Aug 17;97(7):e660-e672. doi: 10.1212/WNL.0000000000012300. Epub 2021 Jun 2. Neurology. 2021. PMID: 34078718 Free PMC article.
-
Signaling pathways and gene co-expression modules associated with cytoskeleton and axon morphology in breast cancer survivors with chronic paclitaxel-induced peripheral neuropathy.Mol Pain. 2019 Jan-Dec;15:1744806919878088. doi: 10.1177/1744806919878088. Mol Pain. 2019. PMID: 31486345 Free PMC article.
-
Prevention of paclitaxel-induced neuropathy by formulation approach.J Control Release. 2019 Jun 10;303:109-116. doi: 10.1016/j.jconrel.2019.04.013. Epub 2019 Apr 11. J Control Release. 2019. PMID: 30981814 Free PMC article.
-
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy.Int J Mol Sci. 2023 Jan 14;24(2):1687. doi: 10.3390/ijms24021687. Int J Mol Sci. 2023. PMID: 36675203 Free PMC article.
-
Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes.Neurotox Res. 2018 Jul;34(1):93-108. doi: 10.1007/s12640-018-9864-8. Epub 2018 Jan 17. Neurotox Res. 2018. PMID: 29344837
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical